Schäfer BW - Search Results

1

The Chromatin Remodeler CHD4 Sustains Ewing Sarcoma Cell Survival by Controlling Global Chromatin Architecture.

Graca Marques J, Pavlovic B, Ngo QA, Pedot G, Roemmele M, Volken L, Kisele S, Perbet R, Wachtel M, Schäfer BW. Graca Marques J, et al. Among authors: schafer bw. Cancer Res. 2024 Jan 16;84(2):241-257. doi: 10.1158/0008-5472.CAN-22-3950. Cancer Res. 2024. PMID: 37963210

2

PAX3 is expressed in human melanomas and contributes to tumor cell survival.

Scholl FA, Kamarashev J, Murmann OV, Geertsen R, Dummer R, Schäfer BW. Scholl FA, et al. Among authors: schafer bw. Cancer Res. 2001 Feb 1;61(3):823-6. Cancer Res. 2001. PMID: 11221862

3

Gene expression signatures identify rhabdomyosarcoma subtypes and detect a novel t(2;2)(q35;p23) translocation fusing PAX3 to NCOA1.

Wachtel M, Dettling M, Koscielniak E, Stegmaier S, Treuner J, Simon-Klingenstein K, Bühlmann P, Niggli FK, Schäfer BW. Wachtel M, et al. Among authors: schafer bw. Cancer Res. 2004 Aug 15;64(16):5539-45. doi: 10.1158/0008-5472.CAN-04-0844. Cancer Res. 2004. PMID: 15313887

4

Subtype and prognostic classification of rhabdomyosarcoma by immunohistochemistry.

Wachtel M, Runge T, Leuschner I, Stegmaier S, Koscielniak E, Treuner J, Odermatt B, Behnke S, Niggli FK, Schäfer BW. Wachtel M, et al. Among authors: schafer bw. J Clin Oncol. 2006 Feb 10;24(5):816-22. doi: 10.1200/JCO.2005.03.4934. Epub 2006 Jan 3. J Clin Oncol. 2006. PMID: 16391296

5

Comparative expression profiling identifies an in vivo target gene signature with TFAP2B as a mediator of the survival function of PAX3/FKHR.

Ebauer M, Wachtel M, Niggli FK, Schäfer BW. Ebauer M, et al. Among authors: schafer bw. Oncogene. 2007 Nov 8;26(51):7267-81. doi: 10.1038/sj.onc.1210525. Epub 2007 May 21. Oncogene. 2007. PMID: 17525748

6

Phosphorylation regulates transcriptional activity of PAX3/FKHR and reveals novel therapeutic possibilities.

Amstutz R, Wachtel M, Troxler H, Kleinert P, Ebauer M, Haneke T, Oehler-Jänne C, Fabbro D, Niggli FK, Schäfer BW. Amstutz R, et al. Among authors: schafer bw. Cancer Res. 2008 May 15;68(10):3767-76. doi: 10.1158/0008-5472.CAN-07-2447. Cancer Res. 2008. PMID: 18483260 Free article.

7

Immunohistochemical detection of EGFR, fibrillin-2, P-cadherin and AP2beta as biomarkers for rhabdomyosarcoma diagnostics.

Grass B, Wachtel M, Behnke S, Leuschner I, Niggli FK, Schäfer BW. Grass B, et al. Among authors: schafer bw. Histopathology. 2009 Jun;54(7):873-9. doi: 10.1111/j.1365-2559.2009.03303.x. Epub 2009 May 11. Histopathology. 2009. PMID: 19469909

8

Cannabinoid receptor 1 is a potential drug target for treatment of translocation-positive rhabdomyosarcoma.

Oesch S, Walter D, Wachtel M, Pretre K, Salazar M, Guzmán M, Velasco G, Schäfer BW. Oesch S, et al. Among authors: schafer bw. Mol Cancer Ther. 2009 Jul;8(7):1838-45. doi: 10.1158/1535-7163.MCT-08-1147. Epub 2009 Jun 9. Mol Cancer Ther. 2009. PMID: 19509271

9

Targets for cancer therapy in childhood sarcomas.

Wachtel M, Schäfer BW. Wachtel M, et al. Among authors: schafer bw. Cancer Treat Rev. 2010 Jun;36(4):318-27. doi: 10.1016/j.ctrv.2010.02.007. Epub 2010 Mar 12. Cancer Treat Rev. 2010. PMID: 20223596 Free article. Review.

10

p21 Downregulation is an important component of PAX3/FKHR oncogenicity and its reactivation by HDAC inhibitors enhances combination treatment.

Hecker RM, Amstutz RA, Wachtel M, Walter D, Niggli FK, Schäfer BW. Hecker RM, et al. Among authors: schafer bw. Oncogene. 2010 Jul 8;29(27):3942-52. doi: 10.1038/onc.2010.145. Epub 2010 May 10. Oncogene. 2010. PMID: 20453878 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters